• SeekInClarity™

    Pan-cancer Recurrence monitoring

    SeekInClarityTM is the first-in-class blood-based pan-cancer treatment response monitoring test. It is a 10ml peripheral blood-based test which uses a cutting edge multivariable cancer recurrence index (molecular tumor burden)model,in conjunction with shallow WGS of cfDNA and a set of specific plasma protein markers detection. MRI model maps the panoramic cancer genome by sWGS data, predicts tumor burden and therapeutic efficacy of the late-stage cancer patients during treatment (including chemotherapy、target therapy and immunotherapy or combined therapy) by evaluating the copy number aberration (CNA) and fragment size (FS),and combinating with 7 plasma protein markers.

    Specifications

    Indicated subjects: Late-stage cancer patients
    Sample requirement: 10ml peripheral blood

    TAT:10 working days

    Results readout: MTB (molecular tumor burden)
    Sampling time:

  •  

    Test Workflow

     
    1

    Pre-test inquiry

    2

    Informed consent

    3

    Blood-draw

    4

    Testing

    5

    Analyzing + Interpretation

    6

    Reporting

    7

    Post-test inquiry

    所有文章
    ×

    ©2018 SeekIn Cancer. All Rights Reserved.